ALS Research Collaboration
  • Home
  • About Us
    • Who we are
    • Our Approach
    • Our Team
    • Our History
  • Our Research
    • Research Focus
    • Participate
    • Studies
    • Current
    • Completed
    • All
    • Publications & Talks
    • Research Vignettes
  • News & Events
  • Support Us
    • Make a donation
  • Contact Us
Select Page

UM Researchers’ Validation of ALS Biomarker Could Accelerate Development of New Therapies

by admin | May 6, 2020 | Press Releases

Researchers at the University of Miami Miller School of Medicine have validated a biomarker for amyotrophic lateral sclerosis (ALS) – a finding that could lead to faster and more efficient clinical trials to develop potential new therapies. “Therapy development for...

CReATe Consortium Aims for ALS Breakthroughs with NIH Renewal Grant

by admin | Oct 4, 2019 | Press Releases

An international research consortium led by investigators at the University of Miami Miller School of Medicine has made significant progress in understanding amyotrophic lateral sclerosis (ALS) and related diseases since its founding in 2014.  Now the Clinical...

Phase III Trial Evaluating Arimoclomol for ALS Patients Reaches Full Enrollment

by admin | Jul 18, 2019 | Press Releases

An international phase III clinical trial evaluating the drug Arimoclomol for the treatment of amyotrophic lateral sclerosis (ALS) has reached full enrollment, as reported by a University of Miami Miller School of Medicine researcher. The current phase III trial...

Recent Posts

  • New Grants Support Six Projects with ‘Ambitious Goal’ of Preventing ALS
  • Dealing ALS a New Hand
  • Miller School Studies Pave the Way for the First Pre-Symptomatic ALS Trial for Individuals with SOD1 Genetic Mutation
  • UM Researchers’ Validation of ALS Biomarker Could Accelerate Development of New Therapies
  • ALS Center investigators host first international Pre-Symptomatic ALS Workshop

Recent Comments

    Latest News

    12/07/22

    Dealing ALS a New Hand

    05/07/21

    Miller School Studies Pave the Way for the First Pre-Symptomatic ALS Trial for Individuals with SOD1 Genetic Mutation

    05/06/20

    UM Researchers’ Validation of ALS Biomarker Could Accelerate Development of New Therapies

    How You Can Help

    Participate in Research

    Make a Donation

    ALS Research Collaboration
    University of Miami,
    Department of Neurology
    1120 NW 14th Street
    Miami, FL 33136

    Search our site

    About Us

    • Who We Are
    • Our Approach
    • Our Team
    • Our History

    Our Research

    • Research Focus
    • Participate
    • All Studies
    • Publications and Talks
    • Research Vignettes

    Support Us

    • Make a Donation

    Search our site

    Copyright 2021 ALS Research Collaboration at University of Miami. All Rights Reserved. Branding by MOK2

    /* ----------------------------------------- */ /* View slug: recent-posts - start */ /* ----------------------------------------- */ .recent-posts { width: 100%; height: auto; } .recent-post-item { width: 100%; height: auto; padding-bottom: 10px; border-bottom: 2px solid #80b918; margin-bottom: 10px; } /* ----------------------------------------- */ /* View slug: recent-posts - end */ /* ----------------------------------------- */